David Weinberg, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Weinberg, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:53 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05364008 · FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green TeaYale University · active not recruiting · Leiomyoma, Uterine · study chair
- Ph3NCT04173169 · Pre-IVF Treatment With a GnRH Antagonist in Women With EndometriosisYale University · completed · Infertility, Endometriosis · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4R01HD100369 · NICHD · YALE UNIVERSITY · PI Hugh Smith Taylor, HEPING ZHANG · fiscal years 2019 to 2023Named on NCT05364008
- Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4R01HD100336 · NICHD · YALE UNIVERSITY · PI Hugh Smith Taylor, HEPING ZHANG · fiscal years 2019 to 2023Named on NCT04173169
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.